secwatch.observer — SEC 8-K summary
======================================

Issuer:     Terns Pharmaceuticals, Inc. (TERN)
CIK:        0001831363
Form:       8-K
Filed at:   2023-03-13T23:59:59+00:00
Accession:  0000950170-23-007597
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Terns Pharmaceuticals states no exposure to SVB failure; operations unaffected
------------------------------------------------------------------------------

- Cash equivalents and marketable securities held at multiple large financial institutions.
- Cash balances in operating accounts also at multiple large banks, not concentrated at SVB.
- Company does not expect any disruptions to operations, including payroll, from recent bank closures.
- Forward-looking statements about sufficiency of cash resources.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831363/000095017023007597/0000950170-23-007597-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831363/000095017023007597/tern-20230313.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-007597

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer